Skip to content
mda-logo_stacked-all white
  • Subscribe
  • Newsletter
  • Advertise
  • MDA.org
  • Donate
Ques_media_logo

Ques_media_logo
Subscribe
Donate

  • Magazine
    • Current Issue
    • Past Issues
  • Featured Content
  • Topics
    • Advocacy
    • Finding a Diagnosis
    • Get Involved
    • Health
    • Inclusion
    • Independence
    • Lifestyle
    • News
    • Personal Stories
    • Science + Research
  • Diseases A-Z
  • Blog
  • Podcast
  • Product Guide
  • Career Quest

Sujatha Gurunathan

Creatine kinase (CK), also known as creatine phosphokinase (CPK) or phosphocreatine kinase, is an enzyme expressed by various tissues and cell types. CK catalyses the conversion of creatine and uses adenosine triphosphate (ATP) to create phosphocreatine (PCr) and adenosine diphosphate (ADP). This CK enzyme reaction is reversible and thus ATP can be generated from PCr and ADP.
Blog Post

Simply Stated: RNA-Based Therapies in Development for Myotonic Dystrophy

By Sujatha Gurunathan | January 30, 2025
Medical Research Scientist Working on Desktop Computer with Gene Analysis Software in Modern Science Research Laboratory. Lab Engineers in White Coats Conduct Experiments in the Background.
Blog Post

Simply Stated: Emerging Therapies to Treat DMD

By Sujatha Gurunathan | December 20, 2024
Gene therapy of the DNA cell. Research changes in the genome of a living organism. Low-poly design of a human hand with a syringe and a spiral-shaped chromosome. Blue background.
Blog Post

Simply Stated: Therapeutic Strategies to Treat DMD

By Sujatha Gurunathan | November 26, 2024
Titled book Amyotrophic Lateral Sclerosis along with medical equipment, Title of book invented and fictitious made in Photoshop, conceptual image
Blog Post

Simply Stated: Updates in Amyotrophic Lateral Sclerosis (ALS)

By Sujatha Gurunathan | October 29, 2024
Blog Post

Simply Stated: Updates in Charcot-Marie-Tooth Disease (CMT)

By Sujatha Gurunathan | September 26, 2024
Blog Post

Clinical Research Alert: Study of Auto Injector Device for People with SMA

By Sujatha Gurunathan | September 4, 2024
3d helix chromosome or Dna structure, technology science background. 3d render illustration
Blog Post

Simply Stated: Revisiting Muscular Dystrophy

By Sujatha Gurunathan | September 3, 2024
DNA and RNA Editing Concept. 3D Illustration
Blog Post

Simply Stated: Updates in Exon Skipping Technology

By Sujatha Gurunathan | July 31, 2024
Protein enzymes fold into their structure to fulfill their function - 3d illustration
Blog Post

Simply Stated: Updates in GNE Myopathy

By Sujatha Gurunathan | June 27, 2024
Blog Post

Clinical Trial Alert: Phase 2 Pivotal Study of Sevasemten (EDG-5506) in Adults with Becker Muscular Dystrophy

By Sujatha Gurunathan | June 17, 2024
  • « Previous
  • 1
  • 2
  • 3
  • 4
  • …
  • 12
  • Next »
  • Media
  • Careers
  • Donate
  • Contact Quest
muscular-dystrophy-association
Muscular Dystrophy Association, Inc.
1016 W Jackson Blvd #1073
Chicago, IL 60607
800-572-1717 | ResourceCenter@mdausa.org

 

Manage Your Quest Media Subscriptions










The Muscular Dystrophy Association (MDA) is a qualified 501(c)(3) tax-exempt organization. ©2022, Muscular Dystrophy Association Inc. All rights reserved.

Privacy Policy | Terms of Use | State Fundraising Notices

Skip to content
Open toolbar Accessibility Tools

Accessibility Tools

  • Increase TextIncrease Text
  • Decrease TextDecrease Text
  • GrayscaleGrayscale
  • High ContrastHigh Contrast
  • Negative ContrastNegative Contrast
  • Light BackgroundLight Background
  • Links UnderlineLinks Underline
  • Readable FontReadable Font
  • Reset Reset